CXCL10 mRNA expression predicts response to neoadjuvant chemoradiotherapy in rectal cancer patients

[1]  P. Coates,et al.  Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue , 2014, Tumor Biology.

[2]  S. Wexner,et al.  Complete Response after Neoadjuvant Therapy in Rectal Cancer: To Operate or Not to Operate? , 2012, Digestive Diseases.

[3]  Yuquan Wei,et al.  Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels. , 2012, Oncology reports.

[4]  R. Bodnar,et al.  An IP-10 (CXCL10)-Derived Peptide Inhibits Angiogenesis , 2012, PloS one.

[5]  Yaoh-Shiang Lin,et al.  Cytoplasmic CD133 Expression is a Reliable Prognostic Indicator of Tumor Regression After Neoadjuvant Concurrent Chemoradiotherapy in Patients with Rectal Cancer , 2012, Annals of Surgical Oncology.

[6]  E. Marcotte,et al.  Insights into the regulation of protein abundance from proteomic and transcriptomic analyses , 2012, Nature Reviews Genetics.

[7]  M. Agostini,et al.  Telomere-Specific Reverse Transcriptase (hTERT) and Cell-free RNA in Plasma as Predictors of Pathologic Tumor Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy , 2012, Annals of Surgical Oncology.

[8]  Biqiong Wang,et al.  CXCL10 enhances radiotherapy effects in HeLa cells through cell cycle redistribution. , 2012, Oncology letters.

[9]  Yasuhiro Inoue,et al.  Evaluation of CXCL10 as a novel serum marker for predicting liver metastasis and prognosis in colorectal cancer. , 2011, International journal of oncology.

[10]  J. Feliu,et al.  A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal Cancer , 2011, Clinical Cancer Research.

[11]  E. Urso,et al.  Circulating Cell-Free DNA: A Promising Marker of Pathologic Tumor Response in Rectal Cancer Patients Receiving Preoperative Chemoradiotherapy , 2011, Annals of Surgical Oncology.

[12]  M. Shimada,et al.  Gene expression profile can predict pathological response to preoperative chemoradiotherapy in rectal cancer. , 2011, Cancer genomics & proteomics.

[13]  Ye Xu,et al.  CXCL10 expression and prognostic significance in stage II and III colorectal cancer , 2010, Molecular Biology Reports.

[14]  D. Aust,et al.  Thymidylate synthase genotypes and tumour regression in stage II/III rectal cancer patients after neoadjuvant fluorouracil-based chemoradiation. , 2008, Cancer letters.

[15]  T. Tamaya,et al.  Expression of IP-10 related to angiogenesis in uterine cervical cancers , 2007, British Journal of Cancer.

[16]  B. Shalmon,et al.  CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. , 2007, Cancer research.

[17]  H. Mehdorn,et al.  Reduced mRNA and protein expression of BCL-2 versus decreased mRNA and increased protein expression of BAX in breast cancer brain metastases: a real-time PCR and immunohistochemical evaluation , 2006, Neurological research.

[18]  K. Song,et al.  Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy. , 2006, International journal of radiation oncology, biology, physics.

[19]  Rakesh K. Jain,et al.  Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors , 2004, Cancer Research.

[20]  A. Dicker,et al.  Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  M. Koukourakis.  Tumour angiogenesis and response to radiotherapy. , 2001, Anticancer research.

[22]  M Ancukiewicz,et al.  Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. , 2000, Cancer research.

[23]  R. Pazdur,et al.  Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. , 1999, International journal of radiation oncology, biology, physics.

[24]  L. Cosmi,et al.  Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B. , 2008, The international journal of biochemistry & cell biology.

[25]  Anne-Laure Boulesteix,et al.  Microarray-based prediction of tumor response to neoadjuvant radiochemotherapy of patients with locally advanced rectal cancer. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[26]  Wh Sit,et al.  Cancer Genomics & Proteomics , 2007 .

[27]  K. Mokbel,et al.  Insulin-like growth factor 1 (IGF-1) and its receptor mRNA levels in breast cancer and adjacent non-neoplastic tissue. , 2006, Anticancer research.